FGFR2 Fusion Cholangiocarcinoma Generic Drug

So, Futibatinib is this thing that stops the FGFR signaling pathway. FGFR is some fancy way of saying a type of growth factor. It’s like a big shot in the arm for cholangiocarcinoma patients, especially those with FGFR2 fusion stuff.

You’ll get these 4 mg pills, but you should take 20 mg of them every day. Each bottle holds a total of 28 tablets. Here’s how it works: it stops the FGFR signaling, which plays a big role in how cholangiocarcinoma with these FGFR2 fusions things gets worse.